I-2019-nCoV S-RBD iNeutralizing Antibody Test Kit (indlela yegolide ye-colloidal)
Intshayelelo
Okwangoku, zonke izitofu zokugonya ze-2019-nCoV kuphuhliso lweklinikhi zilawulwa ngenaliti ye-intramuscular.Ugonyo lwe-Intramuscular okanye lwe-intradermal lungakhokelela ekufakweni okunamandla kwe-serum IgG
Bangaphezulu kwe-180 abagqatswa bogonyo, ngokusekwe kumaqonga ahlukeneyo ahlukeneyo asaphuhlayo ngokuchasene ne-2019-nCoV.
Iprotheyini ye-S yeyona nto iphambili ekujoliswe kuyo kwi-neutralizing antibodies;
Uninzi lwezi zithinteli-zifo zijolisa kwi-RBD ye-S protein.
Ukugweba njani ukusebenza kakuhle kwesitofu sokugonya sika-2019-nCoV?
Inzuzo
Uvavanyo lwesitofu sangaphambili
Ngaphambi kokugonywa, abaviwa banokufumanisa i-antibody engathathi hlangothi ye-RBD ukufumanisa ukuba ugonyo luyimfuneko;
Uninzi lwamachiza lugqunyiwe
Iyakwazi ukubona izithinteli-zifo ezizizo eziveliswa luninzi lwamayeza okugonya emarikeni;
Ukukhawuleza kwaye kulula
Umsebenzi ulula, akukho sixhobo sokukhangela esifunekayo, iziphumo zingafumaneka kwimizuzu eyi-15.
Umsebenzi wokuchonga
Inokwahlula i-antibody engathathi hlangothi ka-2019-nCoV eveliswe sisitofu sokugonya sika-2019-nCoV okanye i-antibody eveliswe lusulelo lwe-2019-nCoV kuhlobo oluthile logonyo, olufana nogonyo lweViral (engaphindaphindiyo), isitofu sokugonya se-RNA kunye nogonyo lweprotheyini. ;
Uvavanyo lwegazi lonke
Uvavanyo lwegazi lonke lwenza utyando lube lula;
Ubungakanani besicelo
Ugonyo lwangaphambili
Qinisekisa ukuba bosulelwe yi-coronavirus entsha nokuba basafuna ukugonywa na;
Ixesha lokugonywa
Ukumisela ukuba ingaba i-antibody entsha engasebenziyo iye yaveliswa;
Inqanaba lamva lokutofa
Ngokwendawo yobhubhane ka-2019-nCoV, kucetyiswa ukuba kubonwe ubukho be-2019-nCoV engathathi hlangothi rhoqo kwiinyanga ezintathu.
Amacandelo
Amacandelo | Izithako eziphambili | Ilayisha ubungakanani (Inkcazo) | ||
1 T/Kit | 20 T/Kit | 50 T/Kit | ||
Ikhadi lovavanyo | Umtya wovavanyo oqulathe i-colloidal yegolide ebhalwe anti-human IgG antibody, igolide ye-colloidal ebhalwe anti-inkukhu IgY antibody, 2019-nCoV S-RBD recombinant protein, Chicken IgY antibody | 1 pc | 20 iipcs | 50 iipcs |
Isampulu yokuxutywa | I-0.01M isisombululo se-Phosphate buffer, 0.5% Tween-20 | 0.5mL | 5mL | 10mL |
Ukusebenza
Hecin reagent | Uvavanyo lweklinikhi lwe-serum virus neutralization | Iyonke | |
Okuhle | Ibi | ||
Okuhle | Okuhle | 84 | 9 |
Ibi | Ibi | 8 | 198 |
Iyonke | Iyonke | 92 | 207 |
Uvakalelo lweklinikhi | Uvakalelo lweklinikhi | 84/92 91.30% (95%CI: 83.58%~96.17%) | |
Ukucaciswa kweklinikhi | Ukucaciswa kweklinikhi | 198/207 95.65% (95%CI: 91.91%~97.99%) | |
Ukuchaneka | Ukuchaneka | 282/299 94.31% (95%CI: 91.05%~96.65%) |
I-Hecin reagent Ukusebenza ngokuchasene neNdlela yoMthelekisi kwi-serum / isampuli zeplasma.
Hecin reagent | Uvavanyo lweklinikhi lwe-serum virus neutralization | Iyonke | |
Okuhle | Ibi | ||
Okuhle | 84 | 8 | 92 |
Ibi | 8 | 199 | 207 |
Iyonke | 92 | 207 | 299 |
Uvakalelo lweklinikhi | 84/92 91.30% (95%CI: 83.58%~96.17%) | ||
Ukucaciswa kweklinikhi | 199/207 96.14% (95%CI: 92.53%~98.32%) | ||
Ukuchaneka | 283/299 94.65% (95%CI: 91.46%~96.91%) |
IHecin reagent Ukusebenza ngokuchasene neNdlela yoMthelekisi kwiisampulu zegazi elipheleleyo.
Inkqubo yoVavanyo
Isatifikethi soBhaliso
JT08- 1T
JT08- 5T
JT08- 50T